Jaguar Health Reports 2021 Third Quarter Financial Results

Mytesi® prescription volume increased 7.6% in Q3 2021 over Q2 2021Third quarter 2021 Mytesi net and gross sales were approximately $0.6 million and approximately $3.2 millionCompany expects to complete transition to selling Mytesi through closed …